Research and Markets: Global Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/d9jzxr/global_pulmonary) has announced the addition of the "Global Pulmonary Fibrosis Drug Pipeline Capsule - 2012 Update" report to their offering.

This report provides information on key Research and Development activities (R&D) in the global Pulmonary Fibrosis market, covering active Pulmonary Fibrosis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

Reasons To Buy:

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

Topics Covered:

1. Pulmonary Fibrosis - Disease Overview

2. Pulmonary Fibrosis Pipeline Overview

3. Pulmonary Fibrosis Phase 3 Clinical Trial Pipeline Insights

4. Pulmonary Fibrosis Phase 2 Clinical Trial Pipeline Insights

5. Pulmonary Fibrosis Phase 1 Clinical Trial Pipeline Insights

6. Pulmonary Fibrosis Preclinical Research Pipeline Insights

7. Pulmonary Fibrosis Discovery Stage Pipeline Insights

8. Pulmonary Fibrosis Drug Development Activities - Geographic Landscape

8.1. Pulmonary Fibrosis R&D Activities in North America

8.2. Pulmonary Fibrosis R&D Activities in Europe

9. Pulmonary Fibrosis Pipeline - Licensing Activities

Table 1. Pulmonary Fibrosis Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Pulmonary Fibrosis Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Pulmonary Fibrosis Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Pulmonary Fibrosis Pipeline Molecules - Preclinical Research

Table 5. Pulmonary Fibrosis Pipeline Molecules - Drug Discovery

Table 6. Pulmonary Fibrosis R&D Activities by Geography

Table 7. Pulmonary Fibrosis Pipeline Molecules - North America

Table 8. Pulmonary Fibrosis Pipeline Molecules - Europe

Table 9. Pulmonary Fibrosis Pipeline - Licensing Activities

Figure 1. Pulmonary Fibrosis Pipeline Molecules by R&D Stage

Figure 2. Pulmonary Fibrosis R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/d9jzxr/global_pulmonary

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals